$36.00 $0.10 per serving
Product analysis
CoQ10 100 mg may support selected blood-vessel and blood-pressure measures in some adults with abnormal blood lipids, with favorable value for its CoQ10 content.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
CoQ10 is clearly identified as ubiquinone. There is not enough information to establish the finished preparation’s quality or an absorption advantage.
Ingredient Transparency100
Both the CoQ10 amount and ubiquinone form are disclosed. That makes the serving straightforward to compare with other CoQ10 preparations.
Value For Money100
The serving offers favorable value for its CoQ10 content. Clear amount and form disclosure make the comparison easier to interpret.
Customer Satisfaction92
Very positive satisfaction is supported by a large volume of ratings. Those impressions do not establish cardiovascular protection or an energy boost.
Product Focus70
The single active has limited support for selected cardiovascular measures. Its normal role in cellular energy does not establish faster metabolism or slower aging.
- Format
Softgel - Container
- 360 Softgel(s)
- Per serving
- $0.10
- Also available
CoQ10 100 mg$21.48- Customer rating
- 4.7 · 41,043 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 100 mg
CoQ10 has limited evidence concerning vascular function, blood pressure and lipids from small trials in selected adults. The declared active amount contributes to the saved comparison. These findings concern intermediate measures and do not establish routine prevention of cardiovascular events or superiority of one delivery form. The 100 mg ubiquinone serving meets part of the saved amount comparison.
How this product is rated for Heart Health
Ingredient fit86
CoQ10 is the focused ingredient, with a declared amount contributing to the saved comparison.
Goal fit
CoQ10 supplies the counted contribution without unrelated actives diluting it.
Dose adequacy
The declared amount meets part of the saved comparison, without establishing a proven preventive dose.
Pathways53
The saved contribution is concentrated in vascular lining function.
Depth
Vascular lining function is the strongest tracked area.
Breadth
Only vascular lining function reaches the breadth comparison.
Evidence98
CoQ10 has limited selected-population evidence for vascular, blood-pressure and lipid measures, without establishing routine cardiovascular-event prevention.
Evidence strength
CoQ10 has limited selected-population evidence for vascular, blood-pressure and lipid measures, without establishing routine cardiovascular-event prevention.
Studied preparation
The saved findings accept the counted preparations, without demonstrating special benefits from their forms.
Formulation logic100
The counted ingredients need no additional partner for their saved contributions. No configured ingredient conflict was matched.
Partner coverage
The counted ingredients work alone or have the required partner in the saved findings.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All counted ingredients reach the saved minimum amount comparison.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 participates in cellular energy production and has limited, preparation-specific evidence for fatigue relief. This product supplies 100 mg per serving in the ubiquinone form. Findings from clinical populations do not establish the same benefit for healthy adults, and this is not an acute alertness effect.
How this product is rated for Energy
Ingredient fit73
CoQ10 accounts for the main relevant ingredients. The 100 mg serving receives partial amount recognition for this preparation; it is not a proven fatigue-treatment dose.
Goal fit
CoQ10 provides the main connection to energy here.
Dose adequacy
The 100 mg serving receives partial amount recognition for this preparation; it is not a proven fatigue-treatment dose.
Pathways17
The main saved connection is mitochondrial energy production, with limited fatigue evidence.
Depth
The main saved connection is mitochondrial energy production, with limited fatigue evidence.
Breadth
No tracked pathway reaches the saved breadth threshold. This does not erase relevant nutrient-sufficiency roles.
Evidence84
Coenzyme Q-10 leads the saved evidence finding, with preparation and population limits.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding, with preparation and population limits.
Studied preparation
The qualifying CoQ10 preparation meets the saved preparation check; this alone does not establish broader fatigue benefits.
Formulation logic100
The relevant ingredients have no unmet partner requirement in the saved findings; this does not establish an added combination benefit.
Partner coverage
The relevant ingredients have no unmet partner requirement in the saved findings; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was matched in the supplied facts.
Effective doses
All counted ingredients meet the saved minimum amount check; that threshold is not proof of clinical benefit.
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 at 100 mg supports normal mitochondrial energy production and antioxidant activity. The supplied aging-related human evidence concerns selected skin changes with a specific water-soluble preparation, which is not matched here. Those findings do not demonstrate longer life or slower systemic aging.
How this product is rated for Longevity
Ingredient fit73
The assessed ingredient mix is relatively focused on the goal’s biological processes. The counted amounts provide partial support relative to the supplied dose ranges.
Goal fit
The assessed ingredient mix is relatively focused on the goal’s biological processes.
Dose adequacy
The counted amounts provide partial support relative to the supplied dose ranges.
Pathways10
The strongest assessed connection is mitochondrial energy production, with limited coverage. No mechanism reaches the saved broader-coverage threshold.
Depth
The strongest assessed connection is mitochondrial energy production, with limited coverage.
Breadth
No mechanism reaches the saved broader-coverage threshold.
Evidence30
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension. The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Evidence strength
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension.
Studied preparation
The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No ingredient conflict was identified in the saved assessment. 1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
CoQ10 may support selected blood-pressure, lipid and blood-vessel markers, with findings from adults with abnormal blood lipids. The supplied ingredient facts declare 100 mg per serving, slightly below the 120 mg used in the reviewed 24-week trial. These findings do not establish prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit86
CoQ10 supplies the main relevant contribution in a declared preparation and amount.
Goal fit
CoQ10 provides a focused cardiovascular-marker contribution, though the product is associated with several goals.
Dose adequacy
The declared 100 mg CoQ10 serving is slightly below the reviewed 120 mg trial exposure.
Pathways53
The contribution centers on function of the blood-vessel lining, with limited coverage of other cardiovascular aspects.
Depth
Function of the blood-vessel lining is the main represented aspect.
Breadth
Support is concentrated in blood-vessel lining function, with no substantial coverage of the other assessed cardiovascular aspects.
Evidence88
CoQ10 has limited marker-based evidence in particular populations, rather than evidence of routine cardiovascular-event prevention.
Evidence strength
CoQ10 supplies the strongest support, based on selected vascular, lipid or blood-pressure markers rather than cardiovascular events.
Studied preparation
The declared CoQ10 active is an accepted preparation; no delivery-form or absorption advantage is established.
Formulation logic100
The included contributors can work independently, their amounts meet the minimum criterion, and no assessed conflict was found.
Partner coverage
CoQ10 can contribute independently; no missing companion reduces the finding.
Conflicts
No assessed ingredient conflict was found.
Effective doses
The included contributors meet the minimum amount criterion; this is not proof that each amount provides clinical benefit.
Impact
High effect
Coenzyme Q-10 · 100 mg
CoQ10 participates in cellular energy production, but this normal role does not establish that supplementation increases whole-body energy use. The supplied findings do not show a lasting metabolism boost or an advantage from a particular CoQ10 form.
How this product is rated for Metabolism Support
Ingredient fit73
CoQ10 accounts for the counted contribution, with its declared serving amount determining the comparison.
Goal fit
CoQ10 supplies the counted goal-related contribution.
Dose adequacy
The counted amounts partly meet the saved references; unknown amounts cannot establish a contribution comparable with studied exposures.
Pathways17
The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Depth
The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Breadth
No evaluated pathway reached the coverage criterion.
Evidence75
The saved evidence comparison accepts nutrient or cellular roles, while the supplied scientific context limits claims of increased energy expenditure.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, but its physiological role or metabolic-marker findings do not establish a routine increase in energy expenditure.
Studied preparation
The counted preparations meet the saved preparation comparison; this does not prove a particular form raises metabolic rate more effectively.
Formulation logic100
There are no unmet partner requirements or configured conflicts. The amount findings describe the counted ingredients, without establishing combined metabolic benefits.
Partner coverage
No counted ingredient has an unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was triggered.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of increased metabolic rate.
Impact
High effect
Coenzyme Q-10 · 100 mg
Ubiquinone CoQ10 has limited relevance to inflammatory markers. A small study in statin-treated people with coronary artery disease found a TNF-alpha difference, while CRP and IL-6 were unchanged. The selected serving provides 100 mg, below the 300 mg daily study exposure; it does not establish the same effect.
How this product is rated for Inflammation
Ingredient fit66
CoQ10 gives the formula a focused connection to this goal. The selected 100 mg serving is below the 300 mg daily exposure used in the limited CoQ10 study.
Goal fit
CoQ10 gives the formula a focused connection to this goal.
Dose adequacy
The selected 100 mg serving is below the 300 mg daily exposure used in the limited CoQ10 study.
Pathways13
CoQ10 is associated mainly with oxidative and mitochondrial stress. No pathway reaches the saved breadth threshold.
Depth
CoQ10 provides the strongest saved connection to oxidative and mitochondrial stress; this describes a mechanism category, not demonstrated clinical relief.
Breadth
No pathway reaches the saved breadth threshold.
Evidence93
Coenzyme Q-10 leads the saved evidence comparison, but the supplied scientific context limits expectations for routine inflammation relief.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, but the supplied scientific context limits expectations for routine inflammation relief.
Studied preparation
The saved findings recognize the counted preparations as studied; this does not establish equivalent benefits across populations.
Formulation logic100
The counted ingredients have no unmet partner requirements or configured conflicts. The counted ingredients clear the saved minimum amount comparison.
Partner coverage
The counted ingredients do not require an additional partner under the supplied findings.
Conflicts
No configured ingredient conflicts were found in the supplied calculation.
Effective doses
The counted ingredients clear the saved minimum amount comparison.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q-10 (Ubiquinone) | 100 mg |
Coenzyme Q-10 (Ubiquinone) · 100 mg OverallScore72
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.